MYC and cancer: In liver cells, treatment with As2O3 correlated with hypomethylation in the cis-regulatory sites of the promoter of MYC (a known cancer-associated gene), as well as hypermethylation in the promoter of MAX (a regulator of MYC and cell cycle) [106].